Cystic Fibrosis Correction with Programmable Genomic Editing
Invention type: Technology
/
Case number: #24666
Researchers
Omar Abudayyeh
/
Christopher Fell
/
Matthew Yarnall
/
Jonathan S. Gootenberg
Departments: McGovern Institute for Brain Research
Technology Areas: Biotechnology: DNA & RNA Editing / Therapeutics: Cell Based Therapy, Regenerative Medicine
Impact Areas: Healthy Living, Advanced Materials
-
systems, methods, and compositions for cystic fibrosis gene editing
Patent Cooperation Treaty | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.